Phase II trial of intravesical camrelizumab in BCG-unresponsive high-risk non-muscle invasive bladder cancer

被引:0
|
作者
Shen, Yijun
Peng, Liangju
Xu, Peihang
Wang, Yanhao
Wang, Xiang
Yao Xudong
Liu, Yushan
Ye, Ding-Wei
机构
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Sch Med, Shanghai, Peoples R China
[3] Tongji Univ, Shanghai Tenth Peoples Hosp, Shanghai, Peoples R China
[4] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Shanghai, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4594
引用
收藏
页数:1
相关论文
共 50 条
  • [1] New Intravesical Agents for BCG-Unresponsive High-Risk Non-Muscle Invasive Bladder Cancer
    Asimakopoulos, Anastasios D.
    Kochergin, Maxim
    Colalillo, Gaia
    Fahmy, Omar
    Hassan, Fahmy
    Renninger, Markus
    Gallioli, Andrea
    Gavrilov, Pavel
    Gakis, Georgios
    BLADDER CANCER, 2023, 9 (03) : 237 - 251
  • [2] HYPERTHERMIC INTRAVESICAL CHEMOTHERAPY FOR BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER
    de Jong, Joep
    Hendricksen, Kees
    Rosier, Marloes
    Boormans, Joost
    Mostafid, Hugh
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1234 - E1235
  • [3] S1605: Phase II trial of atezolizumab in BCG-unresponsive non-muscle invasive bladder cancer
    Singh, Parminder
    Catherine, Tangen
    Lerner, Seth P.
    McConkey, David
    Plets, Melissa
    Lucia, M. Scott
    Woods, Michael
    Bivalacqua, Trinity
    Kassouf, Wassim
    Bangs, Richard Carlton
    Thompson, Ian Murchie
    Black, Peter C.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [4] Current advances in BCG-unresponsive non-muscle invasive bladder cancer
    Tse, Jennifer
    Singla, Nirmish
    Ghandour, Rashed
    Lotan, Yair
    Margulis, Vitaly
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (09) : 757 - 770
  • [5] PHASE 3 RESULTS OF VICINIUM IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER
    Shore, Neal
    O'Donnell, Michael
    Keane, Thomas
    Jewett, Michael A. S.
    Kulkarni, Girish S.
    Dickstein, Rian
    Wolk, Fred
    Dunshee, Curtis
    Belkoff, Laurence
    Dillon, Rachelle L.
    Cizeau, Jeannick
    Kassouf, Wassim
    JOURNAL OF UROLOGY, 2020, 203 : E72 - E72
  • [6] Adaptive Immune Resistance to Intravesical BCG in Non-Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials
    Kates, Max
    Matoso, Andres
    Choi, Woonyoung
    Baras, Alexander S.
    Daniels, Marcus J.
    Lombardo, Kara
    Brant, Aaron
    Mikkilineni, Nina
    McConkey, David J.
    Kamat, Ashish M.
    Svatek, Robert S.
    Porten, Sima P.
    Meeks, Joshua J.
    Lerner, Seth P.
    Dinney, Colin P.
    Black, Peter C.
    McKiernan, James M.
    Anderson, Chris
    Drake, Charles G.
    Bivalacqua, Trinity J.
    CLINICAL CANCER RESEARCH, 2020, 26 (04) : 882 - 891
  • [7] Therapeutic Advances in Bladder Preservation for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
    Lange, Alyssa
    Madiraju, Srigita
    Petros, Firas G.
    CANCERS, 2025, 17 (04)
  • [8] BCG-unresponsive non-muscle invasive bladder cancer: recommendations from the IBCG
    Kamat, Ashish M.
    Colombel, Marc
    Sundi, Debasish
    Lamm, Donald
    Boehle, Andreas
    Brausi, Maurizio
    Buckley, Roger
    Persad, Raj
    Palou, Joan
    Soloway, Mark
    Witjes, J. Alfred
    NATURE REVIEWS UROLOGY, 2017, 14 (04) : 244 - 255
  • [9] Developments in conservative treatment for BCG-unresponsive non-muscle invasive bladder cancer
    Dutto, Daniele
    Livoti, Simone
    Soria, Francesco
    Gontero, Paolo
    EXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (10) : 1335 - 1348
  • [10] Long-term efficacy of hyperthermic intravesical chemotherapy for BCG-unresponsive non-muscle invasive bladder cancer
    Pijpers, Olga M.
    Hendricksen, Kees
    Mostafid, Hugh
    de Jong, Florus C.
    Rosier, Marloes
    Mayor, Nikhil
    de Jong, Joep J.
    Boormans, Joost L.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (02) : 62.e13 - 62.e20